FDA Approved: QUVIVIQ — Supplemental Application (Idorsia Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved a supplemental application for QUVIVIQ (daridorexant) submitted by Idorsia Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• QUVIVIQ (daridorexant)

Snippet

SUPPL AP for QUVIVIQ (DARIDOREXANT)